---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-165656"
form_type: "8-K"
ticker: "AURA"
cik: "0001501796"
company_name: "Aura Biosciences, Inc."
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:49:02.351114+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Aura Biosciences shareholders approve officer exculpation amendment, re-elect directors

## Summary
- Amendment to Tenth Amended Certificate limits officer liability per Delaware law; effective June 20, 2024.
- Directors Antony Mattessich (28.3M for) and Sapna Srivastava (31.9M for) re-elected as Class III directors.
- Ernst & Young ratified as independent auditor for FY 2024 with 38.7M votes for, 5,843 against.
- Charter amendment filed as Exhibit 3.1; all proposals passed with broker non-votes on first two items.

## SEC filing metadata
- accession: 0001193125-24-165656
- form_type: 8-K
- ticker: AURA
- cik: 0001501796
- company_name: Aura Biosciences, Inc.
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501796/000119312524165656/0001193125-24-165656-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501796/000119312524165656/d783830d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-165656
- JSON: https://secwatch.observer/filing/0001193125-24-165656.json
- Plain text: https://secwatch.observer/filing/0001193125-24-165656.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.